U.S. Securities & Exchange Commission
SEC Seal
Home | Previous Page
U.S. Securities and Exchange Commission

SEC NEWS DIGEST

Issue 2013-221
November 18, 2013

ENFORCEMENT PROCEEDINGS

SEC Files Subpoena Enforcement Action against Edward M. Daspin for Failure to Testify in Offering Fraud Investigation

On November 14, 2013, the Securities and Exchange Commission (Commission) filed a subpoena enforcement action against Edward Michael Daspin, also known as "Edward Michael" and "Ed Michael" (Daspin). The action, filed in the U.S. District Court for the Southern District of New York, seeks a court order directing Daspin to comply with an investigative subpoena calling for his testimony in an ongoing investigation into, among other possible violations of the securities laws, potential fraud in the offer and sale of securities of three related companies, Worldwide Mixed Martial Arts Sports, Inc., WMMA Distribution, Inc. and WMMA Holdings, Inc.

The SEC is seeking a court order directing Daspin to appear for testimony on a date acceptable to the Commission. A hearing on the Commission's application has been scheduled for November 27th. The Commission notes that it is continuing to conduct a fact-finding inquiry and has not concluded that anyone has broken the law. [S.E.C. v. Edward M. Daspin, a/k/a "Edward Michael," a/k/a "Ed Michael," 13 Misc. 00389 (S.D.N.Y. November 14, 2013)] (LR-22871)

Self-regulatory organizations

Immediate Effectiveness of Proposed Rule Change

A proposed rule change filed by Chicago Stock Exchange, Inc. (SR-CHX-2013-19) to correct certain rule taxonomy issues and postpone until December 2, 2013 the operative date of an approved proposed rule change has become effective pursuant to Section 19(b)(3)(A) of the Securities Exchange Act of 1934. Publication is expected in the Federal Register during the week of November 18, 2013. (Rel. 34-70894)

Securities Act Registrations

The following registration statements have been filed with the SEC under the Securities Act of 1933. The reported information appears as follows: Form, Name, Address and Phone Number (if available) of the issuer of the security; Title and the number and/or face amount of the securities being offered; Name of the managing underwriter or depositor (if applicable); File number and date filed; Assigned Branch; and a designation if the statement is a New Issue.

Registration statements may be viewed in person in the Commission's Public Reference Branch at 100 F Street, N.E., Washington, D.C. To obtain paper copies, please refer to information on the Commission's Web site at http://www.sec.gov/answers/publicdocs.htm. In most cases, you can view and download this information by using the search function located at http://www.sec.gov/edgar/searchedgar/companysearch.html.

S-4     UMPQUA HOLDINGS CORP, ONE SW COLUMBIA STREET, SUITE 1200, PORTLAND, OR,
97258, 503-727-4100 - 0 ($1,979,486,600.00) Equity, (File 333-192346 -
Nov. 15) (BR. 07B)

S-8     SYSCO CORP, 1390 ENCLAVE PKWY, HOUSTON, TX, 77077, 281-584-1390 -
55,600,000 ($1,833,132,000.00) Equity, (File 333-192353 - Nov. 15)
(BR. 02C)

S-8     Synthetic Biologics, Inc., 155 GIBBS STREET, SUITE 412, ROCKVILLE, MD,
20850, (734) 332-7800 - 3,000,000 ($4,350,000.00) Equity,
(File 333-192355 - Nov. 15) (BR. 01A)

S-3     GENTIVA HEALTH SERVICES INC, 3350 RIVERWOOD PARKWAY, SUITE 1400,
ATLANTA, GA, 30339, 7709516450 - 0 ($53,032,725.14) Equity,
(File 333-192356 - Nov. 15) (BR. 09A)

S-1     UniTek Global Services, Inc., 1777 SENTRY PARKWAY WEST,
GWYNEDD HALL, SUITE 302, BLUE BELL, PA, 19422, 267-464-1700 -
0 ($4,511,491.11) Equity, (File 333-192357 - Nov. 15) (BR. 11C)

S-8     JGWPT Holdings Inc., 201 KING OF PRUSSIA ROAD, SUITE 501, RADNOR, PA,
19087-5148, (484) 434-2300 - 0 ($37,729,509.45) Equity,
(File 333-192359 - Nov. 15) (BR. 07)

S-1     CYTODYN INC, 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660,
971-204-0382 - 0 ($42,439,452.00) Equity, (File 333-192361 - Nov. 15)
(BR. 01B)

S-1     Semler Scientific, Inc., 2330 N.W. EVERETT STREET, PORTLAND, OR, 97210,
408-627-4557 - 0 ($15,815,217.00) Equity, (File 333-192362 - Nov. 15)
(BR. 10B)

S-3ASR  Ascent Capital Group, Inc., 12300 LIBERTY BOULEVARD, ENGELWOOD, CO,
80112, 720-875-5622 - 0 ($21,029,172.33) Equity, (File 333-192363 -
Nov. 15) (BR. 11C)

S-1     Retrophin, Inc., 777 THIRD AVENUE 22ND FLOOR, NEW YORK, NY, 10017,
212-983-1310 - 13,602,234 ($67,084,059.54) Equity, (File 333-192364 -
Nov. 15) (BR. 01B)

S-1     COMMITTED CAPITAL ACQUISITION Corp, 411 W. 14TH STREET, 2ND FLOOR,
NEW YORK, NY, 10014, 212 277 5351 - 7,243,850 ($39,986,052.00) Equity,
(File 333-192365 - Nov. 15) (BR. 05A)

S-3ASR  METLIFE INC, 1095 AVENUE OF AMERICAS, NEW YORK, NY, 10036,
212-578-5500 - 0 ($0.00) Unallocated (Universal) Shelf,
(File 333-192366 - Nov. 15) (BR. 01B)

S-3     Bancorp, Inc., 302-385-5000 - 100,000,000 ($100,000,000.00) Equity,
(File 333-192367 - Nov. 15) (BR. 07C)

S-8     InvenSense Inc, 1745 TECHNOLOGY DRIVE, SAN JOSE, CA, 95110,
(408) 988-7339 - 400,000 ($6,320,000.00) Equity, (File 333-192368 -
Nov. 15) (BR. 10A)

S-3ASR  UNITED PARCEL SERVICE INC, 55 GLENLAKE PARKWAY NE, ATLANTA, GA, 30328,
4048286000 - 0 ($0.00) Other, (File 333-192369 - Nov. 15) (BR. 05C)

N-2     CM Finance Inc, 399 PARK AVENUE, 39TH FLOOR, NEW YORK, NY, 10022,
212-388-5813 - 0 ($115,000,000.00) Equity, (File 333-192370 - Nov. 15)
(BR. 18)

N-2     Guggenheim Floating Rate & Income Fund, 2455 CORPORATE WEST DRIVE,
LISLE, IL, 60532, 630-505-3700 - 40,000 ($1,000,000.00) Equity,
(File 333-192371 - Nov. 15) (BR. )

S-1     Adamis Pharmaceuticals Corp, 11455 EL CAMINO REAL, SUITE 310,
SAN DIEGO, CA, 92130, (858) 997-2400 - 0 ($26,562,500.00) Equity,
(File 333-192372 - Nov. 15) (BR. 01A)

S-4     Sabine Pass Liquefaction, LLC, 700 MILAM ST., SUITE 800, HOUSTON, TX,
77002, (713) 375-5000 - 3,000,000,000 ($3,000,000,000.00) Debt,
(File 333-192373 - Nov. 15) (BR. )

 

Recent 8K Filings

Form 8-K is used by companies to file current reports on the following events:

1.01

Entry into a Material Definitive Agreement

1.02

Termination of a Material Definitive Agreement

1.03

Bankruptcy or Receivership

2.01

Completion of Acquisition or Disposition of Assets

2.02

Results of Operations and Financial Condition

2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

2.04

Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

2.05

Cost Associated with Exit or Disposal Activities

2.06

Material Impairments

3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

3.02

Unregistered Sales of Equity Securities

3.03

Material Modifications to Rights of Security Holders

4.01

Changes in Registrant's Certifying Accountant

4.02

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

5.01

Changes in Control of Registrant

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officer

5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

5.04

Temporary Suspension of Trading Under Registrant's Employee Benefit Plans

5.05

Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics

5.06

Change in Shell Company Status

6.01

ABS Informational and Computational Material.

6.02

Change of Servicer or Trustee.

6.03

Change in Credit Enhancement or Other External Support.

6.04

Failure to Make a Required Distribution.

6.05

Securities Act Updating Disclosure.

7.01

Regulation FD Disclosure

8.01

Other Events

9.01

Financial Statements and Exhibits

Form 8-K filings can be researched through several SEC EDGAR searches, some of which have item filtering functionality.